Search Results 121-130 of 16974 for Antagonist

  1. Publications - Xuan Ding, M.D., Ph.D. - Mayo Clinic

    Investigation of clinical pharmacokinetic variability of an opioid antagonist through physiologically based absorption modeling. J Pharm Sci. 2013 Aug; 102 ...

  2. Oncology (Medical) - Clinical trials

    Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...

  3. (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis - Mayo Clinic

    − Histamine receptor type 1 (H1) antagonist; − Histamine receptor type 2 (H2) antagonist; − Cromolyn sodium; − Leukotriene receptor antagonist ...

  4. An Investigational Drug (TPST-1495) In Patients With Familial Adenomatous Polyposis - Mayo Clinic

    TPST-1495 is a dual antagonist of the prostaglandin E2 (PGE2) receptor subtypes EP2 and EP4, while sparing the immune-stimulating EP1 and EP3 receptors.

  5. A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure - Mayo Clinic

    In blocking the TRPV4 ion channel and reducing pulmonary interstitial fluid, GSK2798745 may improve pulmonary function, respiration, and gas exchange as well as ...

  6. Publications - Daniel D. Borgeson, M.D. - Mayo Clinic

    ... antagonism. Clin Sci (Lond). 1998 Aug; 95(2):195-202. View PubMed; Luchner A ... Chronic oral endothelin type A receptor antagonism in experimental heart failure.

  7. Hematology - Clinical trials

    Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...

  8. AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke - Mayo Clinic

    Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke. Yaghi S. Shadi; Kamel H. Hooman; Elkind MS. Mitchell S V ...

  9. A Study of Atrial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke - Mayo Clinic

    Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke. Yaghi S. Shadi; Kamel H. Hooman; Elkind MS. Mitchell S V ...

  10. New progress in development of gene therapy for arthritis - Mayo Clinic

    A cDNA encoding the interleukin-1 receptor antagonist (IL-1Ra) was delivered to the metacarpophalangeal joints in nine patients with rheumatoid arthritis.